Recently, GEN website released "2018 billionaire TOP10" list.The list shows that the 10 richest people have a cumulative value of 122.Of the $6.1 billion, four of the company's top executives were worth more than $1 billion, ranking first in Incyte Pharmaceuticals Chief Independent Director Julian C.Baker, worth as much as 31.$4 billion.
GEN points out that in the 2017 list, there are five executives worth more than $1 billion, and the total value of TOP10 is 131.4.4 billion.This largely reflects the secondary market share price in the "roller coaster", the stock price plummeted in 2016, 2017 rebound, 2018 down.
Compared to last year's list, two new faces appeared in this year's list, namely Jeffrey C, a director of Perrigo Corporation.Smith and Patrick Soon-Shiong (Chen Songxiong), Chairman of CEO &, NantHealth/NantKwest, in order of value.$9.5 billion and 4.$9.1 billion.
Last year on the list and this year on the list, two of them were Acetlion CEO Jean-Paul Clozel and active investor William A.Ackman, which sold all its shares in Valeant Pharmaceuticals in 2017.
The following is the specific list of the "2018 Billionaire TOP10" list.
2018 billionaire TOP10 (unit: US $)
GEN also made predictions on the 2019 list, which speculated that at least two new faces would emerge in 2019, namely from the board chairman and CEO of mRNA Therapy New Moderna Therapeutics.
On November 11 this year, Moderna submitted an IPO prospectus to the Securities and Exchange Commission of the United States (SEC) to raise 500 million U.S. dollars for IPO; on November 28, the company raised the amount of IPO raised to 600 million U.S. dollars.
According to Moderna's modified S-1/A document, Chairman Noubar B.Afeyan holds 58, 882, 696 shares (19.5%), CEO Stéphane Bancel holds 30, 942, 575 shares (10%).
According to the high value of the Moderna stock price range of $24/share, the total value of the former stock will reach 14.$1.3 billion, while the latter would reach 7.$4.3 billion, enough to be on the GEN list of billionaires in any given year.Even at a low value of $22 a share, the total value of the two shares will reach 12.$9.5 billion and 6.$8.1 billion, ranking fourth and eighth on this year's list.
However, as GEN has commented, with the ups and downs of the stock price in the secondary market, the "worth" is not stable, and the ranking of the wealthy people's worth also changes with the change of the stock price they hold.But at the same time, it also shows that people have been to the "billionaire" club.